Martyn Greenacre

Martyn D.
Greenacre is currently Chairman at Curis, Inc. since 2017, Chairman at Life Mist Technologies, Inc. since 2002, and Director at Formula Pharmaceuticals, Inc. Former roles include President & Chief Executive Officer at Zynaxis, Inc. in 1997, Chief Executive Officer & Director at Delsys Pharmaceutical Corp.
in 2001, Chairman at Life Mist LLC from 2001 to 2016, Chairman at Beijing Med-Pharm Corp.
in 2008, Director & Chairman-European Operations at Smithkline Beecham Pharmaceuticals (India) Ltd. from 1989 to 1992, Chairman at BMP Sunstone Corp.
from 2004 to 2011, Director at Cephalon LLC from 1992 to 2011, Director at Creative Biomolecules, Inc. from 1993 to 2000, Director at Orchestra Therapeutics, Inc. in 2008, Director at Acusphere, Inc. from 2001 to 2013, Director at NeoStem, Inc., Director at Caladrius Biosciences, Inc. in 2011, Member-Executive Committee at Applera Corp., and Senior Advisor at Arsenal Capital Management LP.
Education includes an MBA from Harvard Business School and undergraduate studies at Harvard College.